{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:06:51Z","timestamp":1747714011829,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.abd.2023.08.017","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T15:42:58Z","timestamp":1718293378000},"page":"778-780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bullous pemphigoid successfully treated with dupilumab"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7734-5272","authenticated-orcid":false,"given":"Daniela de Abreu e Silva","family":"Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6514-8801","authenticated-orcid":false,"given":"Amanda de Freitas Sampaio","family":"Periquito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6011-2687","authenticated-orcid":false,"given":"Graciela Galva","family":"Roa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0683-2741","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Lupi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0011-1651","authenticated-orcid":false,"given":"Curt Mafra","family":"Treu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2628-2312","authenticated-orcid":false,"given":"Omar","family":"Lupi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2023.08.017_bib0005","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.3390\/jcm11123367","article-title":"Use of dupilumab in bullous pemphigoid: where are we now?","volume":"11","author":"Russo","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.abd.2023.08.017_bib0010","article-title":"Efficacy and safety of dupilumab in moderate-to-severe bullous pemphigoid","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2023.08.017_bib0015","article-title":"Bullous pemphigoid: the role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2023.08.017_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jdcr.2022.09.017","article-title":"Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient","volume":"29","author":"Zhou","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.abd.2023.08.017_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/abd1806-4841.2019940207","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology","volume":"94","author":"Santi","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2023.08.017_bib0030","doi-asserted-by":"crossref","DOI":"10.5070\/D3274053155","article-title":"Successful treatment of bullous pemphigoid with dupilumab: a case and brief review of the literature","volume":"27","author":"Saleh","year":"2021","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.abd.2023.08.017_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109788","article-title":"Nine cases of refractory bullous pemphigoid treated with dupilumab and literature review","volume":"116","author":"Liang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.abd.2023.08.017_bib0040","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/ijd.16525","article-title":"Dupilumab as a novel therapy for bullous pemphigoid","volume":"62","author":"Zhang","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2023.08.017_bib0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.18176\/jiaci.0682","article-title":"Dupilumab: A review of present indications and off-label uses","volume":"32","author":"Mu\u00f1oz-Bellido","year":"2022","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.abd.2023.08.017_bib0050","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European academy of dermatology and venereology (Eadv)","volume":"36","author":"Borradori","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:51Z","timestamp":1747666851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059624001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0365059624001156"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2023.08.017","relation":{},"ISSN":["0365-0596"],"issn-type":[{"type":"print","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bullous pemphigoid successfully treated with dupilumab","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2023.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}